StudyFinder

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Recruiting
I'm interested

Not specified
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• Received at least one gene-modified (GM) T-cell infusion in a previous Celgene sponsored or Celgene alliance partner-sponsored study, and have discontinued, or completed the post-treatment follow-up period in the parent treatment protocol, as applicable.
• Must understand and voluntarily sign an Informed Consent Form/Informed Assent Form prior to any study-related assessments/procedures being conducted.
Exclusion Criteria:
Not Applicable Other protocol-defined inclusion/exclusion criteria apply

Genetic: Gene-modified (GM) T cell therapy

Neoplasms

Long-term follow up, Gene-Modified T Cells, CAR T Cell

BMS Study Connect Contact Center www.BMSStudyConnect.com - Clinical.Trials@bms.com
McCarty, John, M.
Phase 2/Phase 3
NCT03435796
See this study on ClinicalTrials.gov

Back